Tscan Therapeutics Inc (TCRX) Insider Trading

Total insider buys:
  • $508,637.24
Total insider sells:
  • $64,008.00
Most recent insider trade:
  • Dec. 18, 2023
Most active insider trader:
  • Brian M Silver
Trader NameDateTitleAmountPriceTypeTotal Value
Dec. 18, 2023Director28,830$4.89Buy$140,978.70
Dec. 14, 2023Director5,000$5.08Buy$25,400.00
June 2, 2023Director37,880$2.63Buy$99,624.40
May 31, 2023Major Shareholder25,400$2.52Sell$64,008.00
Dec. 27, 2022CFO2,842$1.50Buy$4,263.00
May 18, 2022CEO25,000$3.59Buy$89,750.00
March 24, 2022CFO15,000$3.40Buy$51,000.00
Sept. 23, 2021Insider4,716$7.48Buy$35,275.68
Sept. 21, 2021CFO5,000$6.32Buy$31,600.00
Sept. 20, 2021Insider4,943$6.22Buy$30,745.46
First«1 of 1»Last
  • Insiders are both buying and selling Tscan Therapeutics Inc stock.

  • The insider traders at Tscan Therapeutics Inc are: Brian M Silver, Timothy J Barberich, Barbara Klencke, Lynx1 Capital Management Lp, Zoran Zdraveski, Gavin Macbeath, and David P Southwell

  • The most active insider trader at Tscan Therapeutics Inc is Brian M Silver with 3 trades.

  • Lynx1 Capital Management Lp has sold the most Tscan Therapeutics Inc stock with a total value of $128,016.00.

  • Timothy J Barberich has bought the most Tscan Therapeutics Inc stock with a total value of $381,581.80.

  • The most recent insider trade for Tscan Therapeutics Inc was on Dec. 18, 2023.

  • The single biggest insider buy for Tscan Therapeutics Inc was from Timothy J Barberich with a total value of $140,978.70 on Dec. 18, 2023.

  • The single biggest insider sell for Tscan Therapeutics Inc was from Lynx1 Capital Management Lp with a total value of $64,008.00 on May 31, 2023.